Navigation Links
Frost & Sullivan Recognizes QRxPharma for Innovative Pain Relief Product MoxDuo
Date:8/17/2010

er pain, while MoxDuo IV can be used in hospitals following surgery by means of patient controlled analgesia (PCA). Recently, the company compared MoxDuo IV in pain following hip replacement, and demonstrated superior pain relief and fewer side effects than PCA morphine, the standard of care.  Development of these additional formulations of MoxDuo serves to maximize the patient population with moderate to severe pain for whom an opioid analgesic is needed and allows the company to address the $12 billion moderate to severe pain relief market from the hospital to the home.

"With its lead compound MoxDuo IR, QRxPharma has established itself as a major participant in the U.S. opioid pain management market; no other opioid-opioid combination product is marketed anywhere in the world," says Symank. "Moreover, the development of multiple formulations of MoxDuo  acts as a positive driver for growth potential and showcases the company's interest in addressing the pain management needs of a variety of patient groups."

In recognition of the company's achievements in innovative new product development, Frost & Sullivan is pleased to present QRxPharma with the 2010 New Product Innovation of the Year Award in the U.S. opioid pain management market. Each year, Frost & Sullivan presents this award to a company that has developed an innovative element in a product by leverage leading-edge technologies. The award recognizes the value added features/benefits of the product and the increased ROI it offers customers, which in turn increases customer acquisition and overall market penetration potential.

Frost & Sullivan's Best Practices Awards recognize companies in a variety of regional and global markets for demonstrating outstanding achievement and superior performance in areas such as leadership, technological innovation, customer service, and strategic product development. Industry analysts compare market participants and measure performan
'/>"/>

SOURCE Frost & Sullivan
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Frost & Sullivan: Western European Markets Confirm Undisputed Convenience and Cost Benefit of Custom Procedure Trays
2. Mennen Medical Receives Frost & Sullivan 2009 European Patient Monitoring Technology Leadership Award
3. Frost & Sullivan Lauds Viatronix as European Medical Imaging Emerging Company of the Year
4. Frost & Sullivan Identifies Focus on Quality Management and Adoption of a Full-service Model as Keys to the Growth of the European CRO Market
5. Widening Application Range to Boost MRI Markets in Eastern Europe, Says Frost & Sullivan
6. Lifesciences IT Spending to Experience Mature Growth Rates Despite Economic Slowdown, Declares Frost & Sullivan
7. Frost & Sullivan Recognizes Holst Centre and imec for Its Path Breaking Wearable Energy Harvester Technology
8. Frost & Sullivan Recognizes Japan Stent Technology for Its Pioneering Coronary Stent Design
9. Central and Eastern European Healthcare Markets Hold Strong Potential for Growth Despite the Economic Slowdown, Says Frost & Sullivan
10. Frost & Sullivan Recognizes Fovia for its HDVR(R) Platform - A Disruptive Technology Breakthrough
11. Frost & Sullivan Recognizes IntelligentMDx for Its Commitment to the Advancement of Healthcare and Diagnostics
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/30/2014)... -- Wrightington, Wigan and Leigh NHS ... ) are delighted to announce WWL,s decision to implement ... system. The system will be implemented across all three ... delivers healthcare in the future. WWL ... and on-budget system implementations as well as its proven ...
(Date:9/30/2014)... ROCKVILLE, Md. , Sept. 30, 2014 /PRNewswire/ ... natural way to modernize medicine, announced today the ... line of nutraceuticals developed to address men and ... staying healthy and vibrant into old age while ... line includes three condition-specific, whole-food and herb-based formulas, ...
(Date:9/30/2014)... Sept. 30, 2014 Arbor Pharmaceuticals, LLC. ... Global Markets Direct,s, ,Arbor Pharmaceuticals, LLC. - ... of the Arbor Pharmaceuticals, LLC.,s pharmaceutical research and ... on the current therapeutic developmental pipeline of Arbor ... stages, therapeutics assessment by drug target, mechanism of ...
Breaking Medicine Technology:Wrightington, Wigan and Leigh NHS Foundation Trust selects Allscripts Sunrise 2Wrightington, Wigan and Leigh NHS Foundation Trust selects Allscripts Sunrise 3Wrightington, Wigan and Leigh NHS Foundation Trust selects Allscripts Sunrise 4Arbor Pharmaceuticals, LLC. - Product Pipeline Review - 2014 2Arbor Pharmaceuticals, LLC. - Product Pipeline Review - 2014 3
... CENTENNIAL, Colo. , May 4 ... today the winners of the 2010 Graeme Clark Cochlear ... Scholarship is awarded to five high school seniors who,ve ... communities.  All recipients have a Nucleus® cochlear implant and ...
... 4 ISTA Pharmaceuticals, Inc. (Nasdaq: ISTA ), today announced it ... pm Pacific Time on May 12, 2010 , in San ... Lauren Silvernail will provide an update on the Company,s marketed products ... The presentation will ...
Cached Medicine Technology:Cochlear Americas Honors Achievements of Cochlear Implant Recipients during May's Better Hearing & Speech Month 2Cochlear Americas Honors Achievements of Cochlear Implant Recipients during May's Better Hearing & Speech Month 3Cochlear Americas Honors Achievements of Cochlear Implant Recipients during May's Better Hearing & Speech Month 4ISTA Pharmaceuticals to Present at the Ninth Annual JMP Securities Research Conference 2
(Date:10/1/2014)... (PRWEB) October 01, 2014 Between 23 ... in the U.S., according to figures from the National ... Diseases Association (AARDA), and many of them have something ... of having undiagnosed celiac disease. Gluten Free Therapeutics, ... awareness of undiagnosed celiac disease by publishing a series ...
(Date:10/1/2014)... Diet Doc understands that many of their clients have ... dieting attempts could be easily sabotaged by the temptation to ... into their programs as a way to control the ... weight loss results, it also allows patients to stick with ... weight for the future. , Earlier versions of the hormone ...
(Date:10/1/2014)... 01, 2014 Anti Aging Clinic (AntiAgingClinic.ca), ... rejuvenating destination of choice, is announcing a discounted cost ... to December. , “We’re doing this because we want ... our top skin clinic in Toronto,” says Dr. Brian ... much at Anti Aging Clinic, including laser facials, genesis ...
(Date:10/1/2014)... 2014 On Sept. 9, Chapín Coffee ... the Martha Stewart American Made Awards (MSAMAs), an annual ... country in the fields of crafts, design, food and ... a finalist in the MSAMAs, which celebrates entrepreneurs and ... improving local communities and changing the way we shop, ...
(Date:10/1/2014)... Nordic Naturals is kicking off ... cause. The campaign—“Buy One Bottle. Help Two Heroes.”—will ... a nonprofit organization that helps rebuild the lives ... that would otherwise face euthanasia. From October through ... monthly donations of Nordic Naturals omega-3s to veterans ...
Breaking Medicine News(10 mins):Health News:Informative New Blog Series Underscores Link Between Celiac Disease and Other Autoimmune Disorders 2Health News:Informative New Blog Series Underscores Link Between Celiac Disease and Other Autoimmune Disorders 3Health News:Diet Doc Announces Their New Version of the Hormone Diet Plan to Target, Attack and Burn Fat Without Dangerous Side Effects 2Health News:Diet Doc Announces Their New Version of the Hormone Diet Plan to Target, Attack and Burn Fat Without Dangerous Side Effects 3Health News:Diet Doc Announces Their New Version of the Hormone Diet Plan to Target, Attack and Burn Fat Without Dangerous Side Effects 4Health News:Anti Aging Clinic, the GTA’s Premier Provider of Anti Aging Treatments, Announces Deal on Units of Botox 2Health News:Chicago Coffee Start-up Makes a Big Impact, Earns National Recognition 2Health News:Nordic Naturals® Inspires Support for Paws for Veterans -- ‘Buy One Bottle. Help Two Heroes.’ Initiative Kicks Off October 1 2
... Analysis finds side effects, loss of effectiveness over time , , ... widely used to treat restless legs syndrome do provide relief, ... loss of effectiveness that causes many sufferers to stop taking ... that we found that we can,t fully explain is that ...
... other influences are limiting the growth ... of frequency and severity of claims, ... leading provider of global risk management and consulting services,today released ... for the first time in nine years of reporting that ...
... a request for proposals, to expand oral health care services; awards ... ... HINSDALE, Ill., May 12 As part of the Illinois,Children,s Healthcare Foundation,s ... Illinois children, the,Foundation is pleased to announce a request for proposals in ...
... cancer exceeds 2/3rds enrolment level - ... peritoneal cancers -, BELLEVILLE, ON, May 12 ... research-based, technology-driven Canadian,biopharmaceutical company, is pleased to provide ... its proprietary platform technology:,Mycobacterial Cell Wall-DNA Complex (MCC)., ...
... blockage more than doubles when these conditions go untreated , , ... high cholesterol levels not only are bad for your heart, ... , The two conditions appear to increase one,s risk for ... It results from one or more veins carrying blood from ...
... use of naproxen might even harm cognitive function , , MONDAY, ... new trial shows that daily use of two popular pain-relieving ... people with a family history of Alzheimer,s disease. , In ... Naprosyn, may even have a deleterious effect on cognitive function, ...
Cached Medicine News:Health News:Drugs for Restless Legs Syndrome Have Downsides 2Health News:Drugs for Restless Legs Syndrome Have Downsides 3Health News:Aon Study Finds Stability in Nationwide Liability Costs in the Long Term Health Care Sector 2Health News:Aon Study Finds Stability in Nationwide Liability Costs in the Long Term Health Care Sector 3Health News:Children in Illinois to Have Healthier Smiles 2Health News:Bioniche Updates re: Mycobacterial Cell Wall Technology Platform 2Health News:Bioniche Updates re: Mycobacterial Cell Wall Technology Platform 3Health News:Bioniche Updates re: Mycobacterial Cell Wall Technology Platform 4Health News:High Blood Pressure, Cholesterol Associated With Eye Disease 2Health News:Celebrex, Naproxen Won't Prevent Mental Decline 2Health News:Celebrex, Naproxen Won't Prevent Mental Decline 3
... testing your blood glucose regularly, you want ... possible. Conventional spring-loaded lancet systems often penetrate ... cause painful dilation or tearing of skin ... a precise, linear action that provides greater ...
... Focus from Thermo Labsystems was designed specifically ... Advanced features such as the new fast ... on microvolumes help to define this as ... The new interchangeable handle plate offers a ...
This CLS number is a new product number, created to easily match Cornings product number. If showing no availability yet, please order under the old Sigma-Aldrich number (Z71,410-0) or contact custom...
... models cover the range from 2ul to 5000ul. ... Volume lock design prevents inadvertent volume change. ... Whole pipette is autoclavable at 121C(250F). ... polypropylene. Suitable for one-handed operation. Auto ...
Medicine Products: